Results 151 to 160 of about 836,001 (298)
Arthritis Care &Research, EarlyView.Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper +7 more
wiley +1 more source
Clinical Pharmacy and Specialization [PDF]
Drug Intelligence & Clinical Pharmacy, 1980 openaire +2 more sources
Changes in PHQ-9 score after clinical pharmacy practitioner intervention in primary care mental health integration clinic. [PDF]
Ment Health ClinGant J, Perryman D, Coveart S.
europepmc +1 more source
Clinical Nuclear Pharmacy Clerkship
American Journal of Pharmaceutical Education, 1977 G L, Dunson, W J, Christopherson
openaire +2 more sources
High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis
Arthritis Care &Research, EarlyView.Objective Although early diagnosis improves long‐term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. Methods We identified 10,021 patients with an incident diagnosis
Anna Costello +5 more
wiley +1 more source
Associations of Rheumatoid Arthritis Disease Activity with Frailty Over Five Years of Follow‐up
Arthritis Care &Research, Accepted Article.Objective To evaluate whether rheumatoid arthritis (RA) disease activity is associated with frailty both in cross‐section and longitudinally. Methods Participants within the Veterans Affairs Rheumatoid Arthritis registry enrolled from 2003 to 2022 were included. The exposure was RA disease activity measured by Disease Activity Score in 28‐joints (DAS28)
Courtney N. Loecker +14 more
wiley +1 more source
Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial. [PDF]
Sci RepSosyal D +3 more
europepmc +1 more source
Arthritis Care &Research, Accepted Article.Objectives Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), yet the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to: 1) identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source